Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

5013

0

WALPAR

img img img img
No Data Available

WALPAR NUTRITIONS LIMITED performance

Today’s low

Today’s high

₹ 47.85 ₹ 47.85
₹ 47.85

52 week low

52 week high

₹ 37.70 ₹ 53.30
₹ 47.85

Open Price

₹ 47.85

Prev. Close

₹ 47.85

Volume (Shares)

2000.00

Total traded value

₹ .95

Upper Circuit

₹ 50.20

Lower Circuit

₹ 45.50

info

WALPAR NUTRITIONS LIMITED Share Price Update

As of the latest trading session, WALPAR NUTRITIONS LIMITED share price is currently at ₹ 47.85, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 47.85 and ₹ 47.85. Over the past year, WALPAR NUTRITIONS LIMITED has achieved a return of -4.29 %. In the last month alone, the return has been 20.83 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

WALPAR NUTRITIONS LIMITED fundamentals


  • Market cap (Cr)

    44.90

  • P/E Ratio (TTM)

    26.58

  • Beta

    0.10

  • Book Value / share

    15.99

  • Return on equity

    11.92%

  • EPS (TTM)

    1.80

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text
  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text

WALPAR NUTRITIONS LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 60.16
Operating Expense 57.83
Net Profit 1.69
Net Profit Margin (%) 2.80
Earnings Per Share (EPS) 1.80
EBITDA 2.94
Effective Tax Rate (%) 30.45
Particulars MAR 2024 (Values in Cr)
Revenue 51.31
Operating Expense 49.97
Net Profit 1.11
Net Profit Margin (%) 2.16
Earnings Per Share (EPS) 2.38
EBITDA 1.90
Effective Tax Rate (%) 25.00
Particulars MAR 2023 (Values in Cr)
Revenue 28.70
Operating Expense 28.51
Net Profit 0.29
Net Profit Margin (%) 1.01
Earnings Per Share (EPS) 0.65
EBITDA 1.05
Effective Tax Rate (%) 34.78
Particulars MAR 2022 (Values in Cr)
Revenue 26.76
Operating Expense 26.45
Net Profit 0.42
Net Profit Margin (%) 1.56
Earnings Per Share (EPS) 0.99
EBITDA 1.10
Effective Tax Rate (%) -23.52
Particulars MAR 2021 (Values in Cr)
Revenue 6.07
Operating Expense 5.91
Net Profit 0.15
Net Profit Margin (%) 2.47
Earnings Per Share (EPS) 0.47
EBITDA 0.45
Effective Tax Rate (%) 6.25
Particulars MAR 2025 (Values in Cr)
Book Value / Share 17.63
ROE % 18.21
ROCE % 17.78
Total Debt to Total Equity 0.53
EBITDA Margin 8.35
Particulars MAR 2024 (Values in Cr)
Book Value / Share 30.21
ROE % 15.06
ROCE % 14.25
Total Debt to Total Equity 0.72
EBITDA Margin 7.95
Particulars MAR 2023 (Values in Cr)
Book Value / Share 25.80
ROE % 7.14
ROCE % 9.44
Total Debt to Total Equity 0.77
EBITDA Margin 10.84
Particulars MAR 2022 (Values in Cr)
Book Value / Share 24.21
ROE % 4.57
ROCE % 4.98
Total Debt to Total Equity 0.93
EBITDA Margin 3.89
Particulars MAR 2021 (Values in Cr)
Book Value / Share 14.30
ROE % 3.14
ROCE % 2.77
Total Debt to Total Equity 1.57
EBITDA Margin 7.58
Particulars MAR 2025 (Values in Cr)
Book Value / Share 15.99
ROE % 11.92
ROCE % 17.64
Total Debt to Total Equity 0.01
EBITDA Margin 4.89
Particulars MAR 2024 (Values in Cr)
Book Value / Share 28.40
ROE % 9.00
ROCE % 11.99
Total Debt to Total Equity 0.14
EBITDA Margin 3.70
Particulars MAR 2023 (Values in Cr)
Book Value / Share 24.92
ROE % 2.60
ROCE % 5.28
Total Debt to Total Equity 0.34
EBITDA Margin 3.66
Particulars MAR 2022 (Values in Cr)
Book Value / Share 24.29
ROE % 5.31
ROCE % 6.39
Total Debt to Total Equity 0.62
EBITDA Margin 4.11
Particulars MAR 2021 (Values in Cr)
Book Value / Share 14.30
ROE % 3.14
ROCE % 3.32
Total Debt to Total Equity 1.14
EBITDA Margin 7.58
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.58
Total Assets 47.38
Total Liabilities 47.38
Total Equity 19.27
Share Outstanding 9390440
Price to Book Ratio 2.65
Return on Assets (%) 4.90
Return on Capital (%) 8.57
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.50
Total Assets 37.16
Total Liabilities 37.16
Total Equity 16.42
Share Outstanding 4695220
Price to Book Ratio 3.71
Return on Assets (%) 4.25
Return on Capital (%) 6.4
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.53
Total Assets 34.30
Total Liabilities 34.30
Total Equity 13.59
Share Outstanding 4541220
Price to Book Ratio 2.03
Return on Assets (%) 1.72
Return on Capital (%) 2.47
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.46
Total Assets 28.09
Total Liabilities 28.09
Total Equity 12.60
Share Outstanding 4541220
Price to Book Ratio 1.11
Return on Assets (%) 1.35
Return on Capital (%) 1.92
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.97
Total Assets 18.00
Total Liabilities 18.00
Total Equity 4.80
Share Outstanding 3341220
Price to Book Ratio 0.00
Return on Assets (%) 0.83
Return on Capital (%) 1.22
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.50
Total Assets 30.92
Total Liabilities 30.92
Total Equity 15.01
Share Outstanding 9390440
Price to Book Ratio 2.65
Return on Assets (%) 5.47
Return on Capital (%) 11.27
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.44
Total Assets 23.49
Total Liabilities 23.49
Total Equity 13.33
Share Outstanding 4695220
Price to Book Ratio 3.71
Return on Assets (%) 4.73
Return on Capital (%) 8.14
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.37
Total Assets 21.85
Total Liabilities 21.85
Total Equity 11.31
Share Outstanding 4541220
Price to Book Ratio 2.03
Return on Assets (%) 1.34
Return on Capital (%) 2.03
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.34
Total Assets 23.35
Total Liabilities 23.35
Total Equity 11.03
Share Outstanding 4541220
Price to Book Ratio 1.11
Return on Assets (%) 1.79
Return on Capital (%) 2.71
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.97
Total Assets 15.69
Total Liabilities 15.69
Total Equity 4.77
Share Outstanding 3341220
Price to Book Ratio 0.00
Return on Assets (%) 0.96
Return on Capital (%) 1.47
Particulars MAR 2024 (Values in Cr)
Net Income 2.49
Cash from Operations 5.52
Cash from Investing -3.60
Cash from Financing -1.77
Net change in Cash -0.03
Free Cash Flow 7.39
Particulars MAR 2023 (Values in Cr)
Net Income 1.11
Cash from Operations 1.17
Cash from Investing -3.44
Cash from Financing 2.41
Net change in Cash 0.07
Free Cash Flow 6.42
Particulars MAR 2022 (Values in Cr)
Net Income 0.27
Cash from Operations -1.01
Cash from Investing -6.14
Cash from Financing 6.71
Net change in Cash -0.51
Free Cash Flow 2.82
Particulars MAR 2021 (Values in Cr)
Net Income 0.16
Cash from Operations -0.31
Cash from Investing -2.01
Cash from Financing 2.95
Net change in Cash 0.62
Free Cash Flow 1.55
Particulars MAR 2025 (Values in Cr)
Net Income 2.43
Cash from Operations 3.04
Cash from Investing -1.23
Cash from Financing -0.41
Net change in Cash 1.06
Free Cash Flow 4.27
Particulars MAR 2024 (Values in Cr)
Net Income 1.47
Cash from Operations 3.24
Cash from Investing -0.88
Cash from Financing -2.18
Net change in Cash 0.07
Free Cash Flow 4.09
Particulars MAR 2023 (Values in Cr)
Net Income 0.45
Cash from Operations 1.16
Cash from Investing 0.45
Cash from Financing -1.51
Net change in Cash 0.03
Free Cash Flow 1.32
Particulars MAR 2022 (Values in Cr)
Net Income 0.33
Cash from Operations -0.25
Cash from Investing -4.58
Cash from Financing 4.26
Net change in Cash -0.63
Free Cash Flow -0.09
Particulars MAR 2021 (Values in Cr)
Net Income 0.16
Cash from Operations 1.37
Cash from Investing -0.69
Cash from Financing -0.06
Net change in Cash 0.62
Free Cash Flow 1.38
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 27.45 13.46 1.42 210.36 25.97 / 57.00
BLISS GVS PHARMA LTD 175.20 16.91 1.63 1853.42 105.05 / 195.85
CIPLA LTD 1466.15 21.77 3.59 118431.38 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 328.00 8.62 2.46 965.34 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 27.45 22.32 3.82 210.36 25.97 / 57.00
AMRUTAJAN HEALTH LTD 627.45 32.00 5.30 1814.00 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 8327.35 90.05 26.05 20818.38 6501.60 / 10653.05
BLISS GVS PHARMA LTD 175.20 23.64 1.67 1853.42 105.05 / 195.85

WALPAR NUTRITIONS LIMITED shareholding pattern

Holding

31.39%
68.6%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

WALPAR NUTRITIONS LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
47.85 0.00 redarrow
red-green-graph indicator
0 Bearish
0 Bullish
  • 5 Days 0.00
  • 26 Days 0.00
  • 10 Days 0.00
  • 50 Days 0.00
  • 12 Days 0.00
  • 100 Days 0.00
  • 20 Days 0.00
  • 200 Days 0.00
47.85 PIVOT

First Support

47.85

First Resistance

47.85

Second Support

47.85

Second Resistance

47.85

Third Support

47.85

Third Resistance

47.85

RSI

59.21

ADX

10.93

MACD

0.00

Williams % R

-21.32

Commodity Channel Index (CCI)

105.61

Date

2025-12-23

Week

2800.00

Same Day

2000.00

Month

2500.00

1 Year

0.10

3 Year

0.28

Over 1 Month

20.83%

down

Over 1 Year

-4.29%

down

Over 3 Months

18.73%

down

Over 3 Years

15.07%

down

Over 6 Months

-2.24%

down

Over 5 Years

10.91%

down

WALPAR NUTRITIONS LIMITED Corporate Actions

Ex-Date Ex-Bonus Ratio
14 Aug 2024 14 Aug 2024 1:1

Top Gainers

WALPAR NUTRITIONS LIMITED Share Price

Walpar Nutritions Limited was originally formed and registered as a Partnership Firm in the name and style of 'M/s Walpar Healthcare', pursuant to a Deed of Partnership dated November 16, 2009. Subsequently, the Constitution of Partnership Firm were changed on March 9, 2015, August 15, 2017 and June 12, 2020 by admission and retirement of Partners. 'M/s. Walpar Healthcare' was thereafter converted from a erstwhile Partnership Firm to a Public Limited Company as 'Walpar Nutritions Limited' and received a Certificate of Incorporation dated December 4, 2020 from the Central Registration Center, Ministry of Corporate Affairs. The Company is primarily engaged in manufacturing, marketing and trading of Pharmaceuticals, Nutraceutical, Herbal and Ayurvedic commodities online and offline.

The Company made a public issue of 12,00,000 Equity Shares of having Face Value of Rs. 10/- each by raising funds aggregating to Rs. 6.60 Crore in July, 2021.

Company initiated as partnership firm i.e. 'M/s. Walpar Healthcare' at Naranpura, Ahmedabad. Initially, it had commenced with the marketing of Ayurvedic Cosmetics and Herbal items. In 2014, it got the manufacturing license of FSSAI license (Food Safety and Standards Authority of India) and commence manufacturing of Nutraceutical products for third party at Hathijan, Ahmedabad. In 2015-16, it moved the manufacturing facilities at Santej, in Gandhinagar. By the year 2015-16, the Company was holding two manufacturing licenses of FSSAI (Food Safety and Standards Authority of India) and AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy) for the dosage form of Tablet, Capsule, Oral liquids and External preparation. Later on, it added three more shed at 4,8 and 9 Shyam Estate, Santej, Ta: Kalol, Gandhinagar, by starting manufacturing of protein powder sachets and facilities expansion.

During the year 2016-2018, the Company started exporting through third party merchandise and by the completion of the year 2016, simultaneously it commenced marketing of their own manufactured Nutraceutical and Ayurvedic products. In 2017, it commenced Reseach and Development activities and prepared first time online platform for B2C suppliers for pharmaceutical raw material, it started catering companies/organization by supplying the majorly Nutraceutical raw material, which is also used as raw material in manufacturing one or more products.

In 2019-20, the Company started first time ever, customized Nutrition under the division of MI supplement and also filed product permission through the merchant exporter in various countries like Nigeria, Vietnam, Phillipines, Ivory coast, Myanmar, Costa Rica, Nepal and Bangladesh. Due to increase in demand of products, it increased the installed capacity of manufacturing of approx. 30 Lakhs tablets per month,1.50 Lakhs oral liquids per month, and 2 Lakhs Sachets per month.

Parent organization Indian Private
NSE symbol WALPAR
Founded 2020
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Walpar Nutritions Ltd?

Answer Field

Walpar Nutritions Ltd share price is for NSE ₹ 47.85 & for BSE ₹ 0.00 as on Dec 23 2025 09:18 AM.

What is the Market Cap of Walpar Nutritions Ltd Share?

Answer Field

The market cap of Walpar Nutritions Ltd for NSE ₹ 44.93 & for BSE ₹ 0.00 as on Dec 23 2025 09:18 AM.

What is the 52 Week High and Low of Walpar Nutritions Ltd?

Answer Field

The 52 Week High and Low of Walpar Nutritions Ltd for NSE is ₹ 53.30 and ₹ 37.70 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Walpar Nutritions Ltd?

Answer Field

The 1 year returns on the stock has been -4.29%.

What is the P/E Ratio of Walpar Nutritions Ltd Share?

Answer Field

As on Dec 23 2025 09:18 AM the price-to-earnings (PE) ratio for Walpar Nutritions Ltd share is 26.58.

What is the PB ratio of Walpar Nutritions Ltd Share?

Answer Field

As on Dec 23 2025 09:18 AM, the price-to-book (PB) ratio for Walpar Nutritions Ltd share is 15.99.

How to Buy Walpar Nutritions Ltd Share?

Answer Field

You can trade in Walpar Nutritions Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Walpar Nutritions Ltd Share on Bajaj Broking App?

Answer Field

To buy Walpar Nutritions Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Walpar Nutritions Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59